YOHEI SEKINO

Last Updated :2024/07/04

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medical), Assistant Professor
Web Site
E-mail
swimminghiroshima-u.ac.jp

Basic Information

Educational Backgrounds

  • Hiroshima University, Graduate School of Biomedical & Health Sciences , Japan, 2014/10, 2018/09
  • Tottori University, Japan, 2000/04, 2007/03

Academic Degrees

  • Hiroshima University

Affiliated Academic Societies

  • the Japanese Urological Association
  • West Japan Urological Association
  • Japanese Society of Endourology
  • The Japanese Cancer Association
  • Japanese Society of Chemotherapy
  • The Japanese Society of Pathology
  • Japanese Society of Medical Oncology
  • The Japanese Tissue Culture Association
  • The Japanese Society for Regenerative Medicine
  • Japan Society of Urologic Oncology

Research Activities

Academic Papers

  1. Fibroblast Growth Factor Family in the Progression of Prostate Cancer., Journal of clinical medicine, 8(2), 2019
  2. Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients., The Prostate, 79(2), 2019
  3. KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer., Journal of clinical medicine, 8(2), 2019
  4. Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer., Oncology reports, 41(5), 2019
  5. Clinicopathological significance of RCAN2 production in gastric carcinoma., Histopathology, 74(3), 2019
  6. SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival., Pathobiology : journal of immunopathology, molecular and cellular biology, 86(4), 2019
  7. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma., Oncology, 97(3), 2019
  8. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer., International journal of molecular sciences, 20(16), 2019
  9. Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosis., Abdominal radiology (New York), 43(7), 2018
  10. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma., Oncology, 95(5), 2018
  11. Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma., BMC cancer, 18(1), 2018
  12. Expression and function of Uc.160+, a transcribed ultraconserved region, in gastric cancer., Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 20(6), 2017
  13. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification., Abdominal radiology (New York), 42(7), 2017
  14. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma., Anticancer research, 37(6), 2017
  15. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer., The Journal of pathology, 243(1), 2017
  16. Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer., Oncotarget, 8(55), 2017
  17. KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer., Urologic oncology, 35(1), 2017
  18. Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer., Oncology letters, 14(1), 2017
  19. Non-coding RNAs are promising targets for stem cell-based cancer therapy., Non-coding RNA research, 2(2), 2017
  20. SUCCESSFUL TREATMENT USING SOMATOSTATIN ANALOGUE FOR POSTOPERATIVE CHYLOUS ASCITES : A CASE REPORT, The Nishinihon journal of urology, 71(3), 111-115, 20090320

Invited Lecture, Oral Presentation, Poster Presentation

  1. KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer., Sekino Y, Oue N, Koike Y, Shigematsu Y, Sakamoto N, Sentani K, Teishima J, Shiota M, Matsubara A, Yasui W., Sekino Y, Oue N, Koike Y, Shigematsu Y, Sakamoto N, Sentani K, Teishima J, Shiota M, Matsubara A, Yasui W., 34th Annual EAU Congress, 2019/03/15, Without Invitation, English, EAU, Barcelona
  2. PCDHB9 promotes resistance to bicalutemide and is associated with the survival of prostate cancer patients, Sekino Y , Goto K. , Sakamoto N , Oue N , Sentani K , Hayashi T,Teishima J, Yasui A , Matsubara A., Sekino Y , Goto K. , Sakamoto N , Oue N , Sentani K , Hayashi T,Teishima J, Yasui A , Matsubara A., 34th Annual EAU Congress, 2019/03/15, Without Invitation, English, EAU, Barcelona
  3. KIFC1 is involved in the regulation of resisitance against docetaxel and a combibation of KIFC1 inhibitor and docetaxel cloud be a promising strategy., Yohei Sekino, Yuki Koike, Yoshinori Shigematsu,Naoya Sakamoto, Masaki Shiota, Kazuhiro Sentani, Naohide Oue, Jun Teishima,Wataru Yasui, Akio Matsubara, Yohei Sekino, Yuki Koike, Yoshinori Shigematsu,Naoya Sakamoto, Masaki Shiota, Kazuhiro Sentani, Naohide Oue, Jun Teishima,Wataru Yasui, Akio Matsubara, 2018/07, Without Invitation, English
  4. Transcribed ultraconserved region UC.63+ promoted docetaxel resistance through Androgen receptor signaling in prostate cancer., SekinoY.SakamotoN.GotoK.HonmaR.ShigematsuY.SentaniK.OueN.TeishimaJ.YasuiW.MatsubaraA., SekinoY.SakamotoN.GotoK.HonmaR.ShigematsuY.SentaniK.OueN.TeishimaJ.YasuiW.MatsubaraA., EAU European Association Urology 2018, 2018/03/16, Without Invitation, English, EAU, Copenhagen
  5. Expression of the transcribed ultraconserved region Uc.63+ in prostate cancer., Sekino Y, Sakamoto N, Goto K, Honma R, Shigematsu Y, Oue N, Sentani K, Teishima J, Matsubara A, Yasui W, Sekino Y, Sakamoto N, Goto K, Honma R, Shigematsu Y, Oue N, Sentani K, Teishima J, Matsubara A, Yasui W, AACR Annual Meeting 2017, 2017/04, Without Invitation, English, AACR, Washington, D.C.